硕世生物 (688399)

Jiangsu Bioperfectus Technologies Co., Ltd.

KSH

Tags

AI HealthcareSpecialized-Sophisticated-Distinctive-Innovative EnterprisesBroker Heavy PositionsPharmaceutical ManufacturingPharmaceuticals and HealthcareGene ConceptNon-GAAP LossesBiological ProductsNew Private Equity HoldingsSTAR Market 200 IndexVitaminsHepatitis ConceptMargin Trading and Securities LendingHigh-Dividend Yield Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 8387.17
  • Circulating A-Shares(W): 8387.17
  • Earnings Per Share(RMB): 0.0400
  • Net Assets Per Share(RMB): 35.3825
  • Operating Revenue(W RMB): 25750.78
  • Total Profit(W RMB): 712.55
  • **Net Profit Attributable to Parent(W RMB) **: 315.17
  • Net Profit Growth Rate(%): -88.38
  • Weighted Return on Equity(%): 0.1000
  • Operating Cash Flow Per Share(RMB): 0.2320
  • Undistributed Profit Per Share(RMB): 26.5472
  • Capital Reserve Per Share(RMB): 7.5578

2. Main Business

The main business covers:

  • Research, development, production and sales of in vitro diagnostic reagents
  • Research, development, production and sales of supporting testing instruments
  • Research, development, production and sales of other in vitro diagnostic products

3. Company Basic Information

  • Company Name: Jiangsu Shuoshi Biotechnology Co., Ltd.
  • Listing Date: 2019-12-05
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 837 Yaocheng Avenue, Taizhou City, Jiangsu Province
  • Website: http://www.s-sbio.com/
  • Company Profile: The company's predecessor Shuoshi Limited was established in April 2010 with a registered capital of RMB 30 million. On April 12, 2010, Shuoshi Limited completed its establishment registration and obtained the Business License. The company was transformed into a joint stock company based on the audited net assets as of October 31, 2016, with a total share capital of 43.96 million shares. On April 10, 2017, Shuoshi Biotechnology completed the establishment registration of the joint stock company at the Taizhou Administration for Industry and Commerce and obtained the Business License.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shaoxing Runkan Biomedical Equity Investment Partnership (Limited Partnership) General Legal Person 2308.80 27.53
2 Taizhou Shuokang Enterprise Management Consulting Partnership (Limited Partnership) General Legal Person 159.84 1.91
3 Taizhou Shuoyuan Enterprise Management Consulting Partnership (Limited Partnership) General Legal Person 159.84 1.91
4 Shenzhen Qianhai Rongqi Fund Management Co., Ltd. - Rongqi Langyage No. 2 Private Securities Investment Fund Private Securities Investment Fund 83.56 1.00
5 China Galaxy Securities Co., Ltd. Securities Company 77.98 0.93
6 Shenzhen Qianhai Rongqi Fund Management Co., Ltd. - Rongqi Langyage No. 6 Private Securities Investment Fund Private Securities Investment Fund 65.65 0.78

5. Concept Sectors

  • Gene Concept
  • Vitamin
  • Hepatitis Concept
  • AI Healthcare
  • Margin Trading & Securities Lending
  • Heavily Held by Securities Companies
  • High Dividend Stocks
  • Non-Recurring Loss
  • Continuous Loss
  • Specialized, Refined, Special and New Enterprises
  • New Private Placement
  • Sci-Tech Innovation 200

Remarks

  • Data update date: 2025-09-30
  • Data source: Public market information